Genflow Biosciences Share Price (GENF)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Genflow Biosciences Plc	LSE:GENF	London	Ordinary Share	GB00BP2C3V08	ORD GBP0.0003

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-0.18	-5.14%	3.32	3,123,414	16:35:04

Bid Price		Offer Price	High Price	Low Price	Open Price
3.30		3.60	3.85	3.45	3.45

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology					10

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
16:42:31	O	50,000	3.80	GBX

Related Shares
Astrazeneca (AZN), Gsk (GSK), N4 Pharma (N4P), Bermele (BERM)

Genflow Biosciences (GENF) Latest News

Genflow Biosciences News

Date	Time	Source	Headline
28/11/2022	16:41	UKREG	Genflow Biosciences PLC Second Price Monitoring Extn
28/11/2022	16:35	UKREG	Genflow Biosciences PLC Price Monitoring Extension
28/11/2022	09:06	UKREG	Genflow Biosciences PLC Second Price Monitoring Extn
28/11/2022	09:00	UKREG	Genflow Biosciences PLC Price Monitoring Extension
23/11/2022	07:44	UKREG	Genflow Biosciences PLC Price Monitoring Extension
14/10/2022	19:22	ALNC	TRADING UPDATES: Pembridge Resources gets payment; Genflow gets award
11/10/2022	06:00	UKREG	Genflow Biosciences PLC Non-Dilutive Grant Research Award
30/9/2022	20:57	ALNC	EARNINGS UPDATES: Ross Group, Goldstone, Caerus interim loss widens
30/9/2022	06:02	UKREG	Genflow Biosciences PLC Half-year results
15/8/2022	06:00	UKREG	Genflow Biosciences PLC Company Share Purchase by CEO

More Genflow Biosciences News

Genflow Biosciences Investors Genflow Biosciences Takeover Rumours

Genflow Biosciences (GENF) Share Charts 1 Year Genflow Biosciences Chart
1 Month Genflow Biosciences Chart	Intraday Genflow Biosciences Chart

Genflow Biosciences (GENF) Discussions and Chat

Genflow Biosciences Forums and Chat

Date	Time	Title	Posts
29/11/2022	18:05	Genflow Biosciences plc 2022	57
28/11/2022	14:23	Old age a thing of the past?	33
15/4/2022	10:31	US SEC indicts key shareholder	-
01/2/2022	11:45	Welcome	3

Add a New Thread

Genflow Biosciences (GENF) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
16:42:31	3.80	50,000	1,900.00	O
16:35:04	3.32	50,000	1,660.00	UT
16:35:00	3.30	250	8.25	O
16:35:00	3.60	138	4.97	O
16:35:00	3.30	540	17.82	O

View all Genflow Biosciences trades in real-time

Genflow Biosciences (GENF) Top Chat Posts

Top Posts
Posted at 29/11/2022 08:20 by Genflow Biosciences Daily Update Genflow Biosciences Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker GENF. The last closing price for Genflow Biosciences was 3.50p. Genflow Biosciences Plc has a 4 week average price of 1.75p and a 12 week average price of 1.75p. The 1 year high share price is 13.25p while the 1 year low share price is currently 1.75p. There are currently 292,506,618 shares in issue and the average daily traded volume is 2,434,864 shares. The market capitalisation of Genflow Biosciences Plc is £9,711,219.72. Read Full Thread Reply
Posted at 28/11/2022 15:04 by moneymunch The answer lies in a 2013 paper published in a highly regarded journal entitled “The Hallmarks of Ageing”... To put it simply, the paper outlines 9 hallmarks of aging that provide a framework for prolonging human life. This roadmap to longevity spawned numerous biotech companies that used it as a roadmap for their R&D. But even the companies regarded as the cream-of-crop are at a disadvantage… They tend to focus on a single hallmark of aging. To quote Eric Leire, the company’s chief executive, “You’ve only solved one-ninth of the problem with this approach.” Genflow Biosciences takes a holistic approach by targeting 4 of the 9 hallmarks directly, in addition to 2 indirectly. They are able to do this by focusing on the SIRT6 gene. This gene’s overexpression has proven to extend the lives of healthy mice, winning it the title of the “master regulator of aging”. This novel research has allowed the company to capture alluring patents, which brings us back to Altos Labs… If anyone wants this IP they would have to purchase the company at a significant premium to the current share price or enter a licensing agreement. Altos Labs opened only a few months ago, in January of 2022. We know that Altos Labs has the ambition and the means to become the leader in longevity tech, and Genflow Biosciences likely holds the keys to that ambition. It stands to reason that the mega-tech startup would team up with or outright buy Genflow Biosciences, launching its extremely undervalued share price to match, or exceed, its peer group. Consider that on mere rumors of acquisition for their LIDAR IP, Microvision’s (MVIS) share price exploded almost 300% in less than 2 weeks last year. Now imagine the sudden news that a Bezo’s backed company set on discovering the formula for immortality is acquiring or partnering with a little-known European biotech start-up with a share price of only 2p News like this could pop at any second. Launching Genflow Biosciences into the spotlight at any time this year. This is a highly competitive industry and players with deep pockets see Genflow Biosciences’ IP as their ticket to the top of the market. If it’s not Altos Labs, then surely there will be another. https://clearcapitalmarkets.co.uk/biotech-opinion-joe-neighbour/?gclid=EAIaIQobChMInZjjq4TP-wIVhLTtCh3iWQGBEAAYASAAEgIBGfD_BwE Read Full Thread Follow Reply
Posted at 01/8/2022 13:53 by dave4545 2.75-2.755p spread So now you can buy size at the bid price and a full penny lower than recent director buys. Read Full Thread Follow Reply
Posted at 29/7/2022 13:51 by felchandbart I like the look of this company. Have been invested here for a couple of weeks now, price has dropped slightly since then but clearly plenty of upside potential. Credible team and well-funded. Can't see it hanging around at these levels for too long. Read Full Thread Follow Reply
Posted at 20/7/2022 07:54 by dave4545 Shame some are selling the same price directors are buying Read Full Thread Follow Reply
Posted at 12/7/2022 08:59 by tomboyb GENF is in the position where no funding is required - Down from header 13p to 2p is a good entry imo - Read Full Thread Follow Reply
Posted at 12/7/2022 08:45 by dave4545 It was 2.35p mid price yesterday, when I saw that trade today I rushed to see if smaller could get that price still but not a bean offered online so it's going to shift. Should have took a starter yesterday as a base. Took the NMS 30k at 2.5p, mm wanted 3p for 100k when 2.5p offer greedy or what Read Full Thread Follow Reply
Posted at 12/7/2022 07:56 by tomboyb Buzz, I think GENF have run out of sellers - Buying and adding a few Biotech - Read Full Thread Follow Reply
Posted at 11/7/2022 08:08 by manual dexterity The difference here having looked at both CIZ and GENF is that CIZ may need funds. GENF has no requirement for fund for the foreseeable future. I do think this has been hit pretty hard, so a decent punt at these levels. Read Full Thread Follow Reply
Posted at 09/6/2022 16:45 by deadly nightshade Buzz if you go back over past few days there were some bigger trades I was trying to work out if it was a big seller and price was going down so it could go through at a certain price like 3p? It's stayed down at this range so not sure what's happening. Where do you see this company going buzz as looking back through posts you have been here from the start, are you still confident buzz? Read Full Thread Follow Reply
Posted at 09/6/2022 13:31 by deadly nightshade Any idea if we have a big seller here as share price is crashing? Someone looks to be off loading big time by the look of the trades? Read Full Thread Follow Reply

Genflow Biosciences share price data is direct from the London Stock Exchange

Your Recent History

LSE

GENF

Genflow Bi..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Advertise Here

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US

P: V: D:20221129 23:50:46